Skip to content
Back to recalls
Drug FDA Class I Ongoing Mislabeling

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

SoloVital Published Aug 7, 2024

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 85/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact SoloVital or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Hazards

Undeclared Diclofenac · primaryUndeclared Omeprazole

Affected products (1)

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

1,331 bottles

Lot codes: within
Code info: All lots within Expiry

Affected areas

Nationwide

Timeline

  1. Initiated
    Jul 12, 2024
  2. Published
    Aug 7, 2024
Recall number
D-0620-2024
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.